GRIP Molecular Technologies
Pre-clinicalGRIP Molecular Technologies is pioneering a molecular test for lateral flow assay readouts with a CRISPR protease-based platform.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $5.1M
About
GRIP Molecular Technologies is pioneering a molecular test for lateral flow assay readouts with a CRISPR protease-based platform.
Diagnostics
Funding History
1Total raised:$5.1M
Seed$5.1MMar 15, 2023